The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients.

Priya SellaturayPadmalal GurugamaVerah Harper Tom DymondPamela EwanShuaib Nasser

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2021)

Patients allergic to PEG, previously denied COVID vaccination, may now be safely vaccinated with the PS80 containing AstraZeneca vaccine and need only avoid the PEG-containing mRNA COVID-19 vaccines. This opens up the possibility that these patients will also tolerate other vaccines containing PS80 such as the Janssen/Johnson and Johnson COVID-19 vaccine. Clinical cross-reactivity between PEG and PS80 did not occur in this vaccine setting.

Keyphrases

end stage renal disease
coronavirus disease
sars cov
newly diagnosed
ejection fraction
chronic kidney disease
drug delivery
prognostic factors
peritoneal dialysis
patient reported outcomes